V J O'Neill

A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

Louis Fehrenbacher, V J O'Neill, Chandra P. Belani et al. · Journal of Clinical Oncology · 2006 · 63 citations

Cancer Pharmacology, Pharmacotherapy, Oncology +17

Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours

G. Pentheroudakis, V J O'Neill, P. Vasey et al. · Supportive Care in Cancer · 2001 · 55 citations

Lymphoid Neoplasia, Tumour Lysis Syndrome, Urology +4

Phase I Trial of Intraperitoneal Injection of the<i>E1B</i>-55-kd-Gene–Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer

P. Vasey, L. Shulman, Susana M. Campos et al. · Journal of Clinical Oncology · 2002 · 45 citations

Phase II study of PRO95780 plus paclitaxel, carboplatin, and bevacizumab (PCB) in non-small cell lung cancer (NSCLC).

Christos S. Karapetis, P. Clingan, N. B. Leighl et al. · Journal of Clinical Oncology · 2010 · 20 citations

Immunology, Pathology, Cell Death +18

Audit of oxygen therapy.

JH Gravil, V J O'Neill, Robin Stevenson · PubMed · 1997 · 10 citations

Arterial Gas Analysis, Pulmonary Care, Ventilation +15